Dogwood Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Dogwood Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $11.40M, a 168.00% increase year-over-year.
- Dogwood Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $4.25M.
- Dogwood Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $1.38M.
- Dogwood Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $1.16M, a 74.27% decline year-over-year.
- Dogwood Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2024 was $1.38M.
- Dogwood Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2022 was $4.49M.
- Dogwood Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2020 was $31.05M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $11.40M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $4.25M 10-Q · filed 2025-11-07 | |
| 2024-12-31 | $1.38M 10-K · filed 2026-03-18 | |
| 2024-06-30 | $1.38M 10-Q · filed 2025-11-07 | |
| 2023-09-30 | $1.16M 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $4.49M 10-K/A · filed 2024-03-08 | |
| 2022-09-30 | $4.49M 10-Q · filed 2023-11-13 | |
| 2020-12-31 | $31.05M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |